Islet Transplantation in Type 1 Diabetes
收藏DataCite Commons2023-01-13 更新2024-07-13 收录
下载链接：
https://repository.niddk.nih.gov/studies/cit-07
下载链接
链接失效反馈官方服务：
资源简介：
The CIT consortium conducted a total of 9 studies across North America (CIT02 through CIT08) and the Nordic region (CIT01). CIT08 was a long-term follow-up study for interested participants at the North American sites. The target population is individuals with type 1 diabetes, normal kidney function, and intractable hypoglycemia. All studies treated participants with up to 3 separate infusions of islets. Subjects in CIT07, a single arm Phase 3 license-enabling study, received induction and maintenance immunosuppression in an open-label fashion consisting of rabbit anti-thymocyte globulin (ATG; basiliximab instead of ATG for the 2nd and 3rd transplants, if applicable), etanercept, sirolimus and low-dose tacrolimus.
提供机构：
NIDDK Central Repository
创建时间：
2023-01-13
